Hepatitis C Virus: 30 Years after Its Discovery.

Area of Science:

• Hepatology and Virology
• Infectious Diseases
• Molecular Biology

Background:

• The existence of a non-A, non-B hepatitis agent was suspected in the mid-1970s.
• A prolonged 15-year search was necessary for pathogen identification.

Purpose of the Study:

• To detail the discovery and impact of the hepatitis C virus (HCV).
• To highlight the development of diagnostics and therapeutics for HCV.
• To discuss the ongoing need for HCV vaccine strategies.

Main Methods:

• Identification of HCV in 1989 utilized recombinant DNA immunoscreening.
• Development of direct-acting antivirals (DAAs) targeted key viral proteins (protease, polymerase, NS5A).
• Clinical trials evaluated interferon-based therapies and DAA combinations.

Main Results:

• Discovery led to blood tests preventing post-transfusion HCV.
• Type 1 interferon showed partial efficacy.
• DAAs offer oral cures for HCV within months with minimal side effects.
• Vaccine strategies are feasible but not yet implemented.

Conclusions:

• The identification of HCV revolutionized hepatitis management.
• Direct-acting antivirals provide a curative treatment for hepatitis C.
• Vaccination is essential for the global eradication of hepatitis C.